Five Prime Therapeutics Stock Price

0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)


52 Week Range


Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Five Prime Therapeutics Inc FPRX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 38.00 20:00:00
Open Price Low Price High Price Close Price Prev Close
38.00 38.00
Bid Price Ask Price Spread News
15.00 41.00 26.00 12 2
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 38.00 USD

Five Prime Therapeutics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.76B 46.32M 37.61M $ 14.87M $ - -3.93 -5.50
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Five Prime Therapeutics News

Date Time Source News Article
4/16/202116:16Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)
4/16/202116:02Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)
4/16/202108:48Edgar (US Regulatory)Notification Filed by National Security Exchange to Report..
4/16/202108:43Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)
4/16/202108:42Seeking AlphaAmgen completes $1.9B acquisition of Five Prime Therapeutics
4/16/202108:39Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)
4/16/202108:38Edgar (US Regulatory)Current Report Filing (8-k)
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical FPRX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week37.9138.0137.9037.97827,2290.090.24%
1 Month37.7038.0137.6037.831,518,3270.300.8%
3 Months13.8138.9013.7733.962,199,50724.19175.16%
6 Months6.1038.904.5024.962,293,47831.90522.95%
1 Year2.8138.902.6122.061,317,77035.191,252.31%
3 Years17.2738.901.7517.51679,77020.73120.03%
5 Years47.0260.981.7522.87580,527-9.02-19.18%

Five Prime Therapeutics Description

Five Prime Therapeutics Inc is a biotechnology company focused on discovering and developing protein therapeutics for diseases. The company's product candidates address patient populations for which therapies are still needed. Its is focused on advancing its internal pipeline and retaining rights for products in targeted specialty markets. It also seeks to establish additional collaborations to supplement its internal development capabilities. These collaborations generate additional funding in order to further validate the company's technology. It has the following product in pipeline: Cabiralizumab, FPA150, Bemarituzumab and Immuno-Oncology.
Your Recent History
Five Prime..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210419 00:28:44